AI assistant
Sending…
CONMED Corp — Director's Dealing 2017
May 16, 2017
31971_dirs_2017-05-16_821663c2-81bd-426d-a637-77cac89286d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-05-15
Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-15 | Common Stock | S | 2500 | $51.2644 | Disposed | 14455 | Direct |
| 2017-05-15 | Common Stock | S | 500 | $51.00 | Disposed | 13955 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.38. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
More from CONMED Corp
Capital/Financing Update
2026
Jun 1
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7